Yongquan Chen

Prof. Yongquan Chen

Wuxi School of Medicine, Jiangnan University
orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2008 in Cancer Letters
Verified
Journal Article
Closed access
IBIsabelle M. Berquin
Isabelle M. Berquin
IEIris J. Edwards
Iris J. Edwards
YCYongquan Chen
Yongquan Chen

1 August 2015 in Immunity
Verified
Journal Article
Closed access
JSJia Sun
Jia Sun
LFLaetitia Furio
Laetitia Furio
RMRamine Mecheri
Ramine Mecheri
ADAnne Van Der Does
Anne Van Der Does
ELErik Lundeberg
Erik Lundeberg
Julien DianaJulien Diana
Julien Diana

28 May 1996 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
Dean G. TangDean G. Tang
Dean G. Tang
YCYongquan Chen
Yongquan Chen
KHK V Honn
K V Honn
Arachidonic acid (AA) metabolites derived from both cyclooxygenase (COX) and lipoxygenase (LOX) pathways transduce a variety of signals related to cell growth. Here, we report that the AA LOX pathway also functions as a critical regulator of cell survival and apoptosis. Rat Walker 256 (W256) carcinosarcoma cells express 12-LOX and synthesize 12(S)- and 15(S)-hydroxyeicosatetraenoic acids as their major LOX metabolites. W256 cells transfected with 12-LOX-specific antisense oligonucleotide or antisense oligonucleotides directed to conserved regions of LOXs underwent time- and dose-dependent apoptosis. Likewise, treatment of W256 cells with various LOX but not COX inhibitors induced apoptotic cell death, which could be partially inhibited by exogenous 12(S)- or 15(S)-hydroxyeicosatetraenoic acids. The W256 cell apoptosis induced by antisense oligos and LOX inhibitors was followed by a rapid downregulation of bcl-2 protein, a dramatic decrease in the bcl-2/bax ratio, and could be suppressed by bcl-2 overexpression. In contrast, p53, which is wild type in W256 cells, did not undergo alterations during apoptosis induction. The results suggest that the LOX pathway plays an important physiological role in regulating apoptosis.

2 July 2007 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
IBIsabelle M. Berquin
Isabelle M. Berquin
YMYounong Min
Younong Min
RWRuping Wu
Ruping Wu
JWJiansheng Wu
Jiansheng Wu
DPDonna Perry
Donna Perry
YCYongquan Chen
Yongquan Chen
Although a causal role of genetic alterations in human cancer is well established, it is still unclear whether dietary fat can modulate cancer risk in a predisposed population. Epidemiological studies suggest that diets rich in omega-3 polyunsaturated fatty acids reduce cancer incidence. To determine the influence of fatty acids on prostate cancer risk in animals with a defined genetic lesion, we used prostate-specific Pten-knockout mice, an immune-competent, orthotopic prostate cancer model, and diets with defined polyunsaturated fatty acid levels. We found that omega-3 fatty acids reduced prostate tumor growth, slowed histopathological progression, and increased survival, whereas omega-6 fatty acids had opposite effects. Introducing an omega-3 desaturase, which converts omega-6 to omega-3 fatty acids, into the Pten-knockout mice reduced tumor growth similarly to the omega-3 diet. Tumors from mice on the omega-3 diet had lower proportions of phosphorylated Bad and higher apoptotic indexes compared with those from mice on omega-6 diet. Knockdown of Bad eliminated omega-3–induced cell death, and introduction of exogenous Bad restored the sensitivity to omega-3 fatty acids. Our data suggest that modulation of prostate cancer development by polyunsaturated fatty acids is mediated in part through Bad-dependent apoptosis. This study highlights the importance of gene-diet interactions in prostate cancer.

1 May 2015 in Journal of Functional Foods
Verified
Journal Article
Closed access
BYBo Yang
Bo Yang
HCHaiqin Chen
Haiqin Chen
CSCatherine Stanton
Catherine Stanton
RRR. Paul Ross
R. Paul Ross
HZHao Zhang
Hao Zhang
WCWei Chen
Wei Chen

1 May 2007 in Journal of Biological Chemistry
Verified
Journal Article
Open access
KSKonduru S.R. Sastry
Konduru S.R. Sastry
YKYelena Karpova
Yelena Karpova
SPSergey Prokopovich
Sergey Prokopovich
ASAdrienne J. Smith
Adrienne J. Smith
BEBrian Essau
Brian Essau
GKGeorge Kulik
George Kulik
The stress hormone epinephrine is known to elicit multiple systemic effects that include changes in cardiovascular parameters and immune responses. However, information about its direct action on cancer cells is limited. Here we provide evidence that epinephrine reduces sensitivity of cancer cells to apoptosis through interaction with beta(2)-adrenergic receptors. The antiapoptotic mechanism of epinephrine primarily involves phosphorylation and inactivation of the proapoptotic protein BAD by cAMP-dependent protein kinase. Moreover, BAD phosphorylation was observed at epinephrine concentrations found after acute and chronic psychosocial stress. Antiapoptotic signaling by epinephrine could be one of the mechanisms by which stress promotes tumorigenesis and decreases the efficacy of anti-cancer therapies.